{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:38:35Z","timestamp":1791189515533,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.neuroscience.2009.08.063","type":"journal-article","created":{"date-parts":[[2009,9,5]],"date-time":"2009-09-05T04:56:14Z","timestamp":1252126574000},"page":"1199-1209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Effects of memantine on soluble A\u03b225-35-induced changes in peptidergic and glial cells in Alzheimer\u2019s disease model rat brain regions"],"prefix":"10.1016","volume":"164","author":[{"given":"M.","family":"Arif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Chikuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md.M.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nakazato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2009.08.063_bib1","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neuroscience.2004.04.024","article-title":"Effect of memantine on the levels of glial cells, neuropeptides, and peptide-degrading enzymes in rat brain regions of the ibotenic acid-treated Alzheimer's disease model","volume":"126","author":"Ahmed","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer's disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib3","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1523\/JNEUROSCI.1933-04.2004","article-title":"Memantine protects hippocampal neuronal function in murine human immunodeficiency virus type 1 encephalitis","volume":"24","author":"Anderson","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib4","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.neuint.2006.01.016","article-title":"Clozapine but not haloperidol suppresses the changes in the levels of neuropeptides in MK-801-treated rat brain regions","volume":"49","author":"Arif","year":"2006","journal-title":"Neurochem Int"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib5","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.neures.2006.10.021","article-title":"Suppressive effect of clozapine but not haloperidol on the increases of neuropeptide-degrading enzymes and glial cells in (+) MK-801-treated rat brain regions","volume":"57","author":"Arif","year":"2007","journal-title":"Neurosci Res"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.neurobiolaging.2004.05.008","article-title":"\u03b2-amyloid peptide depresses excitatory synaptic transmission in the rat basolateral amygdala \u201cin vitro\u201d","volume":"26","author":"Ashenafi","year":"2005","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0896-6273(03)00607-X","article-title":"Glial cells and neurotransmission: an inclusive view of synaptic function","volume":"40","author":"Auld","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.mce.2008.01.014","article-title":"Somatostatin and Alzheimer's disease","volume":"286","author":"Burgos-Ramos","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib9","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00401-006-0071-y","article-title":"Neuropathology of Alzheimer disease: pathognomonic but not pathogenic","volume":"111","author":"Castellani","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0006-8993(99)01494-8","article-title":"The association of metalloendopeptidase EC 3.4.24.15 at the extracellular surface of the AtT-20 cell plasma membrane","volume":"835","author":"Crack","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00001756-199612200-00018","article-title":"\u03b2-amyloid produces a delayed NMDA receptor dependent reduction in synaptic transmission in rat hippocampus","volume":"8","author":"Cullen","year":"1996","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0197-4580(95)00013-5","article-title":"Correlations of synaptic and pathological markers with cognition of the elderly","volume":"16","author":"Dickson","year":"1995","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib14","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nn842","article-title":"Immunization reverses memory deficits without reducing brain A-beta burden in Alzheimer's disease model","volume":"5","author":"Dodart","year":"2002","journal-title":"Natl Neurosci"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0006-3223(95)00066-6","article-title":"Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex","volume":"39","author":"Gabriel","year":"1996","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib17","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0924-977X(95)80009-Q","article-title":"Neuropeptides and Alzheimer's disease","volume":"5","author":"Gottfries","year":"1995","journal-title":"Eur Neuropsychopharamacol"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF03160172","article-title":"Differential responses of rat cerebral somatostatinergic and cholinergic cells to glutamate agonists","volume":"19","author":"Ham","year":"1993","journal-title":"Mol Chem Neuropathol"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib18a","doi-asserted-by":"crossref","first-page":"8876","DOI":"10.1523\/JNEUROSCI.19-20-08876.1999","article-title":"Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons","volume":"19","author":"Hartley","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib19","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.bjp.0704362","article-title":"Somatostatin release by glutamate in vivo is primarily regulated by AMPA receptors","volume":"134","author":"Hathway","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib20","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1073\/pnas.96.6.3228","article-title":"Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models","volume":"96","author":"Hsia","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0006-8993(93)91105-2","article-title":"Facilitatory effects of substance P on the susceptibility to long-term potentiation in the visual cortex of adult rats","volume":"617","author":"Kato","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1471-4159.1980.tb03687.x","article-title":"Changes in prolyl endopeptidase during maturation of rat brain and hydrolysis of substance P by the purified enzymes","volume":"35","author":"Kato","year":"1980","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2108\/zsj.19.93","article-title":"Expression and localization of prolyl oligopeptidase in mouse testis and its possible involvement in sperm motility","volume":"19","author":"Kimura","year":"2002","journal-title":"Zool Sci"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib25","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nm1234","article-title":"Amyloid b protein immunotherapy neutralizes Ab oligomers that disrupt synaptic plasticity in vivo","volume":"11","author":"Klyubin","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib26","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.brainres.2004.10.041","article-title":"Soluble A\u03b2 oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer\u2019s disease brain","volume":"1031","author":"Kokubo","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib28","doi-asserted-by":"crossref","first-page":"7247","DOI":"10.1073\/pnas.88.16.7247","article-title":"An vivo model for the neurodegenerative effects of \u03b2-amyloid and protection by substance P","volume":"88","author":"Kowall","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.pnpbp.2004.11.017","article-title":"Effects of substance P and its antagonist L-733060 on long term potentiation in guinea pig hippocampal slices","volume":"29","author":"Langosch","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/156720506775697124","article-title":"Amyloid beta: the alternate hypothesis","volume":"3","author":"Lee","year":"2006","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00424-002-0999-2","article-title":"Cholinergic modulation of the cortical neuronal network","volume":"446","author":"Lucas-Meunier","year":"2003","journal-title":"Eur J Physiol"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib32","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","article-title":"Soluble amyloid beta peptide concentration as predictor of synaptic change in Alzheimer's disease","volume":"155","author":"Lue","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0165-0327(98)00086-X","article-title":"Higher serum prolyl endopeptidase activity in patients with post-traumatic stress disorder","volume":"53","author":"Maes","year":"1999","journal-title":"J Affect Disord"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib34","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1097\/00001756-200009280-00032","article-title":"Kindled seizure-evoked somatostatin release in the hippocampus: inhibition by MK-801","volume":"28","author":"Marti","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0304-3940(91)90455-3","article-title":"A facilitatory role of endogenous somatostatin in long-term potentiation of the mossy fiber-CA3 system in guinea-pig hippocampus","volume":"129","author":"Matsuoka","year":"1991","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib37","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","article-title":"Soluble pool of A\u03b2 amyloid as a determinant of severity of neurodegeneration in Alzheimer\u2019s disease","volume":"46","author":"McLean","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ana.410420114","article-title":"Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease","volume":"42","author":"Minoshima","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib39","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0006-8993(02)03731-9","article-title":"Neuroprotection by memantine against neurodegeneration induced by \u03b2-amyloid 1\u201340","volume":"958","author":"Miguel-Hidalgo","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib40","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/j.1471-4159.2004.02451.x","article-title":"MGLuR5 activation reduces \u03b2-amyloid-induced cell death in primary neuronal cultures and attenuates translocation of cytochrome c and apoptosis-inducing factor","volume":"89","author":"Movsesyan","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0361-9230(99)00196-3","article-title":"Reduction of somatostatin and substance P levels and choline acetyltransferase activity in the cortex and hippocampus of the rat after chronic intracerebroventricular infusion of \u03b2-amyloid (1\u201340)","volume":"50","author":"Nag","year":"1999","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib43","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0006-8993(96)00233-8","article-title":"Facilitatory role of somatostatin via muscarinic cholinergic system in the generation of long-term potentiation in the rat dendate gyrus in vivo","volume":"723","author":"Nakata","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(98)01002-6","article-title":"Delayed behavioral effects following intrahippocampal injection of aggregated A beta (1\u201342)","volume":"815","author":"O'Hare","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib44a","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib45a","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.neuint.2003.07.005","article-title":"Contribution of astrocytes to synaptic transmission in the rat supraoptic nucleus","volume":"45","author":"Piet","year":"2004","journal-title":"Neurochem Int"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib45","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1046\/j.1471-4159.1995.64010253.x","article-title":"Structure-activity analyses of \u03b2-amyloid peptides: contributions of the \u03b225-35 region to aggregation and neurotoxicity","volume":"64","author":"Pike","year":"1995","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib46","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1527-3458.2003.tb00254.x","article-title":"The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease","volume":"9","author":"Rogawaski","year":"2003","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib47","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0143-4179(02)00029-X","article-title":"The ability of hippocampal CA1 area for induction of long-term potentiation is persistently reduced by prior treatment with cysteamine: an in vitro study","volume":"36","author":"Rostampour","year":"2002","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib48","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1002\/jnr.21713","article-title":"Memantine leads to behavioral improvement and amyloid reduction in Alzheimer's-disease-model transgenic mice shown as by micromagnetic resonance imaging","volume":"86","author":"Scholtzova","year":"2008","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib49","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer's disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib49a","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/ncb1104-1054","article-title":"Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases","volume":"6","author":"Selkoe","year":"2004","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2004.05.005","article-title":"Dementia of Alzheimer's disease and other neurodegenerative disorders-memantine, a new hope","volume":"51","author":"Sonkusare","year":"2005","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib51","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1111\/j.1460-9568.2008.06498.x","article-title":"Memantine protects rat cortical cultured neurons against \u03b2-amyloid-induced toxicity by attenuating tau","volume":"28","author":"Song","year":"2008","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib52","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1152\/jn.00230.2001","article-title":"Impairment of hippocampal CA1 heterosynaptic transformation and spatial memory by \u03b2-amyloid25-35","volume":"87","author":"Sun","year":"2002","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib53","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0197-0186(89)90076-4","article-title":"A rapid enzyme immunoassay for cholecystokinin octapeptide sulfate","volume":"15","author":"Takeda","year":"1989","journal-title":"Neurohem Int"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib54","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-510X(98)00240-8","article-title":"Affected enzyme activities in Alzheimer's disease are sensitive to antemortem hypoxia","volume":"161","author":"Terwel","year":"1998","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib55","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/S0022-3565(25)10670-8","article-title":"JTP-4819: A novel prolyl endopeptidase inhibitor with potential cognitive enhancer","volume":"274","author":"Toide","year":"1995","journal-title":"J Phramacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib56","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of amyloid \u03b2 protein potently inhibit hippocampal long-term potentiation in vivo","volume":"416","author":"Walsh","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib57","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuron.2004.09.010","article-title":"Deciphering the molecular basis of memory failure in Alzheimer's disease","volume":"44","author":"Walsh","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib58","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/0269881108089820","article-title":"Behavioural signs of depression and apoptosis in the limbic system","volume":"23","author":"Wann","year":"2007","journal-title":"J Psychopharamacol"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib59","doi-asserted-by":"crossref","first-page":"B315","DOI":"10.1093\/gerona\/50A.5.B315","article-title":"Alterations of substance P metabolism and neuropeptidases in Alzheimer's disease","volume":"50","author":"Waters","year":"1995","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib60","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1749-6632.1997.tb46142.x","article-title":"Alterations of peptide metabolism and neuropeptidase activity in senile dementia of the Alzheimer's type","volume":"814","author":"Waters","year":"1997","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.neuroscience.2009.08.063_bib61","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1254\/jphs.92.400","article-title":"Changes in the levels of neuropeptides and their metabolizing enzymes in the brain regions of nucleus basalis magnocellularis-lesioned rats","volume":"92","author":"Yamamoto","year":"2003","journal-title":"J Pharmacol Sci"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452209014237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452209014237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:05:17Z","timestamp":1773680717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452209014237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0306452209014237"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2009.08.063","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of memantine on soluble A\u03b225-35-induced changes in peptidergic and glial cells in Alzheimer\u2019s disease model rat brain regions","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2009.08.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 IBRO. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}